Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1966 2
1967 3
1969 2
1970 1
1971 1
1972 1
1974 1
1976 3
1977 1
1981 1
1983 1
1984 1
1985 1
1987 2
1988 1
1989 3
1990 7
1991 7
1992 11
1993 4
1994 6
1995 6
1996 8
1997 6
1998 6
1999 8
2000 4
2001 8
2002 8
2003 6
2004 6
2005 6
2006 5
2007 7
2008 4
2009 8
2010 5
2011 5
2012 4
2014 2
2015 12
2016 7
2017 5
2018 13
2019 12
2020 13
2021 13
2022 10
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
The therapy of idiopathic pulmonary fibrosis: what is next?
Somogyi V, Chaudhuri N, Torrisi SE, Kahn N, Müller V, Kreuter M. Somogyi V, et al. Among authors: kahn n. Eur Respir Rev. 2019 Sep 4;28(153):190021. doi: 10.1183/16000617.0021-2019. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31484664 Free PMC article. Review.
Evolution and treatment of idiopathic pulmonary fibrosis.
Torrisi SE, Kahn N, Vancheri C, Kreuter M. Torrisi SE, et al. Among authors: kahn n. Presse Med. 2020 Jun;49(2):104025. doi: 10.1016/j.lpm.2020.104025. Epub 2020 May 11. Presse Med. 2020. PMID: 32437841 Review.
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Among authors: kahn n. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study.
Röhrich M, Leitz D, Glatting FM, Wefers AK, Weinheimer O, Flechsig P, Kahn N, Mall MA, Giesel FL, Kratochwil C, Huber PE, Deimling AV, Heußel CP, Kauczor HU, Kreuter M, Haberkorn U. Röhrich M, et al. Among authors: kahn n. J Nucl Med. 2022 Jan;63(1):127-133. doi: 10.2967/jnumed.121.261925. Epub 2021 Jul 16. J Nucl Med. 2022. PMID: 34272325 Free PMC article.
Studying burnout.
Addison RB, Kahn NB Jr. Addison RB, et al. Among authors: kahn nb jr. Fam Pract Res J. 1994 Sep;14(3):207-10. Fam Pract Res J. 1994. PMID: 7976471 No abstract available.
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.
Karampitsakos T, Spagnolo P, Mogulkoc N, Wuyts WA, Tomassetti S, Bendstrup E, Molina-Molina M, Manali ED, Unat ÖS, Bonella F, Kahn N, Kolilekas L, Rosi E, Gori L, Ravaglia C, Poletti V, Daniil Z, Prior TS, Papanikolaou IC, Aso S, Tryfon S, Papakosta D, Tzilas V, Balestro E, Papiris S, Antoniou K, Bouros D, Wells A, Kreuter M, Tzouvelekis A. Karampitsakos T, et al. Among authors: kahn n. Respirology. 2023 Jan;28(1):56-65. doi: 10.1111/resp.14363. Epub 2022 Sep 18. Respirology. 2023. PMID: 36117239
Tomography of Feshbach resonance states.
Margulis B, Horn KP, Reich DM, Upadhyay M, Kahn N, Christianen A, van der Avoird A, Groenenboom GC, Meuwly M, Koch CP, Narevicius E. Margulis B, et al. Among authors: kahn n. Science. 2023 Apr 7;380(6640):77-81. doi: 10.1126/science.adf9888. Epub 2023 Apr 6. Science. 2023. PMID: 37023184
[Exacerbation in Idiopathic Pulmonary Fibrosis].
Polke M, Kahn N, Kreuter M. Polke M, et al. Among authors: kahn n. Pneumologie. 2021 Aug;75(8):601-610. doi: 10.1055/a-1273-4105. Epub 2021 Aug 9. Pneumologie. 2021. PMID: 34374062 German.
252 results